We were able to show this same association between screening status and prognosis even within the largest intrinsic subtype groups (Table 4): patients with screen-detected luminal A-like and luminal B-like (HER2-negative) subtypes had better prognosis in comparison to patients with interval cancers and those not attending screening. Here, ERBB2 is linked to cancer.